Captopril AL

Captopril AL may be available in the countries listed below.

Ingredient matches for Captopril AL

Captopril

Captopril is reported as an ingredient of Captopril AL in the following countries:

• Czech Republic


• Germany

International Drug Name Search

Triostat

Triostat is a brand name of liothyronine, approved by the FDA in the following formulation(s):

TRIOSTAT (liothyronine sodium - injectable; injection)

• 
  Manufacturer: JHP PHARMS
  
  Approval date: December 31, 1991
  
  Strength(s): EQ 0.01MG BASE/ML ^[RLD][AP]

Has a generic version of Triostat been approved?

Yes. The following products are equivalent to Triostat:

liothyronine sodium injectable; injection

• 
  Manufacturer: X GEN PHARMS
  
  Approval date: August 17, 2005
  
  Strength(s): EQ 0.01MG BASE/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Triostat. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Triostat.

See also...

• Triostat Consumer Information (Wolters Kluwer)
• Triostat Advanced Consumer Information (Micromedex)
• Liothyronine Consumer Information (Wolters Kluwer)
• Liothyronine Tablets Consumer Information (Wolters Kluwer)
• Liothyronine Consumer Information (Cerner Multum)
• Liothyronine Advanced Consumer Information (Micromedex)
• Liothyronine Intravenous Advanced Consumer Information (Micromedex)
• Liothyronine Sodium AHFS DI Monographs (ASHP)

Octonativ-M

Octonativ-M may be available in the countries listed below.

Ingredient matches for Octonativ-M

Coagulation Factor VIII, Human

Coagulation Factor VIII, Human is reported as an ingredient of Octonativ-M in the following countries:

• Tunisia

International Drug Name Search

Hymecromon

Hymecromon may be available in the countries listed below.

Ingredient matches for Hymecromon

Hymecromone

Hymecromone is reported as an ingredient of Hymecromon in the following countries:

• Georgia

International Drug Name Search

Gramoce A

Gramoce A may be available in the countries listed below.

Ingredient matches for Gramoce A

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Gramoce A in the following countries:

• Spain

Retinol

Retinol is reported as an ingredient of Gramoce A in the following countries:

• Spain

International Drug Name Search

Timonal

Timonal may be available in the countries listed below.

Ingredient matches for Timonal

Tiemonium Methylsulfate

Tiemonium Methylsulfate is reported as an ingredient of Timonal in the following countries:

• Algeria

International Drug Name Search

Oleptro Extended-Release Tablets

Pronunciation: TRAZ-oh-done
Generic Name: Trazodone
Brand Name: Oleptro

Antidepressants may increase the risk of suicidal thoughts or actions in children, teenagers, and young adults. However, depression and certain other mental problems may also increase the risk of suicide. Talk with the patient's doctor to be sure that the benefits of using Oleptro Extended-Release Tablets outweigh the risks.

Family and caregivers must closely watch patients who take Oleptro Extended-Release Tablets. It is important to keep in close contact with the patient's doctor. Tell the doctor right away if the patient has symptoms like worsened depression, suicidal thoughts, or changes in behavior. Discuss any questions with the patient's doctor.

Oleptro Extended-Release Tablets are used for:

Treating depression. It may also be used for other conditions as determined by your doctor.

Oleptro Extended-Release Tablets are an antidepressant. It is thought to increase the activity of one of the brain chemicals (serotonin), which helps elevate mood.

Do NOT use Oleptro Extended-Release Tablets if:

• you are allergic to any ingredient in Oleptro Extended-Release Tablets or nefazodone


• you are taking sodium oxybate (GHB) or tryptophan


• you are taking or have taken linezolid, methylene blue, or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Video: Treatment for Depression

Treatments for depression are getting better everyday and there are things you can start doing right away.

Before using Oleptro Extended-Release Tablets:

Some medical conditions may interact with Oleptro Extended-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have an irregular heartbeat (eg, long QT syndrome), other heart problems, low blood pressure, or have had a heart attack


• if you or a family member has a history of bipolar disorder (manic-depression), other mental or mood problems, suicidal thoughts or attempts, or alcohol or substance abuse


• if you have liver problems, kidney problems, low blood sodium levels, low blood potassium levels, or low blood magnesium levels


• if you have sickle cell anemia, multiple myeloma, a deformed penis (eg, angulation, cavernosal fibrosis, Peyronie disease), or leukemia


• if you are dehydrated

Some MEDICINES MAY INTERACT with Oleptro Extended-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin), aspirin, or nonsteroidal anti-inflammatory drugs (NSAIDs) (eg, ibuprofen) because the risk of bleeding may be increased


• Antipsychotics (eg, olanzapine, haloperidol), linezolid, MAOIs, (eg, phenelzine), methylene blue, phenothiazines (eg, thioridazine), selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs) (eg, duloxetine, venlafaxine), "triptans" (eg, sumatriptan), or tryptophan because severe side effects, such as a reaction that may include fever, rigid muscles, blood pressure changes, mental changes, confusion, irritability, agitation, delirium, or coma, may occur


• Diuretics (eg, furosemide, hydrochlorothiazide) because the risk of low blood sodium levels may be increased


• Azole antifungals (eg, ketoconazole), delavirdine, or HIV protease inhibitors (eg, ritonavir) because the risk of Oleptro Extended-Release Tablets's side effects may be increased


• Carbamazepine because it may decrease Oleptro Extended-Release Tablets's effectiveness


• Amiodarone, barbiturates (eg, phenobarbital), buspirone, digoxin, hydantoins (eg, phenytoin), nefazodone, sodium oxybate (GHB), or medicine for high blood pressure because the risk of their side effects may be increased by Oleptro Extended-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Oleptro Extended-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Oleptro Extended-Release Tablets:

Use Oleptro Extended-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Oleptro Extended-Release Tablets comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Oleptro Extended-Release Tablets refilled.


• Take Oleptro Extended-Release Tablets by mouth on an empty stomach at least 1 hour before or 2 hours after eating.


• Take Oleptro Extended-Release Tablets at bedtime unless your doctor tells you otherwise.


• Swallow Oleptro Extended-Release Tablets whole. Do not crush or chew before swallowing. If your doctor tells you to break Oleptro Extended-Release Tablets in half, be sure to break the tablet along the score line.


• Oleptro Extended-Release Tablets works best if it is taken at the same time each day.


• Continue to take Oleptro Extended-Release Tablets even if you feel well. Do not miss any doses.


• Do not suddenly stop taking Oleptro Extended-Release Tablets. You may experience side effects, such as anxiety, agitation, or trouble sleeping. If you need to stop Oleptro Extended-Release Tablets or add a new medicine, your doctor will gradually lower your dose.


• If you miss a dose of Oleptro Extended-Release Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Oleptro Extended-Release Tablets.

Important safety information:

• Oleptro Extended-Release Tablets may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Oleptro Extended-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Oleptro Extended-Release Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Oleptro Extended-Release Tablets may cause dizziness, lightheadedness, or fainting; alcohol. hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Tell your doctor or dentist that you take Oleptro Extended-Release Tablets before you receive any medical or dental care, emergency care, or surgery.


• Children, teenagers, and young adults who take Oleptro Extended-Release Tablets may be at increased risk of suicidal thoughts or actions. Watch all patients who take Oleptro Extended-Release Tablets closely. Contact the doctor at once if new, worsened, or sudden symptoms such as depressed mood; anxious, restless, or irritable behavior; panic attacks; or any unusual change in mood or behavior occur. Contact the doctor right away if any signs of suicidal thoughts or actions occur.


• Neuroleptic malignant syndrome (NMS) is a possibly fatal syndrome that can be caused by Oleptro Extended-Release Tablets. Symptoms may include fever; stiff muscles; confusion; abnormal thinking; fast or irregular heartbeat; and sweating. Contact your doctor at once if you have any of these symptoms.


• Serotonin syndrome is a possibly fatal syndrome that can be caused by Oleptro Extended-Release Tablets. Your risk may be greater if you take Oleptro Extended-Release Tablets with certain other medicines (eg, "triptans," MAOIs). Symptoms may include agitation; confusion; hallucinations; coma; fever; fast or irregular heartbeat; tremor; excessive sweating; and nausea, vomiting, or diarrhea. Contact your doctor at once if you have any of these symptoms.


• Oleptro Extended-Release Tablets may rarely cause a prolonged, painful erection. This could happen even when you are not having sex. If this is not treated right away, it could lead to permanent sexual problems such as impotence. Contact your doctor right away if this happens.


• Use Oleptro Extended-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially low blood sodium levels.


• Oleptro Extended-Release Tablets should not be used in CHILDREN or TEENAGERS; safety and effectiveness have not been confirmed. Children and teenagers may also be more sensitive to its effects, especially the increased risk of suicidal thoughts or actions.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Oleptro Extended-Release Tablets while you are pregnant. Oleptro Extended-Release Tablets are found in breast milk. If you are or will be breast-feeding while you use Oleptro Extended-Release Tablets, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Oleptro Extended-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Blurred vision; constipation; decreased sexual desire or ability; dizziness; drowsiness; dry mouth; headache; lightheadedness when sitting up or standing; nausea; tiredness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); black, tarry, or bloody stools; chest pain; decreased coordination; fainting; hallucinations; irregular heartbeat; new or worsening agitation, anxiety, panic attacks, aggressiveness, impulsiveness, irritability, hostility, exaggerated feeling of well-being, restlessness, trouble sleeping, or inability to sit still; prolonged, painful erection; seizures; severe or persistent dizziness; shortness of breath; suicidal thoughts or actions; swelling of the hands, ankles, or feet; symptoms of low blood sodium levels (eg, confusion, persistent headache, trouble concentrating, memory problems, weakness, unsteadiness, sluggishness, personality changes); tremor; unusual bruising or bleeding; vomit that looks like coffee grounds; worsening depression.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Oleptro side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include irregular heartbeat; prolonged, painful erection; seizures; severe drowsiness; slow or shallow breathing; vomiting.

Proper storage of Oleptro Extended-Release Tablets:

Store Oleptro Extended-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C) in a tight, light-resistant container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oleptro Extended-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Oleptro Extended-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Oleptro Extended-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is summary only. It does not contain all information about Oleptro Extended-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Oleptro resources

• Oleptro Side Effects (in more detail)
• Oleptro Dosage
• Oleptro Use in Pregnancy & Breastfeeding
• Oleptro Drug Interactions
• Oleptro Support Group
• 4 Reviews for Oleptro - Add your own review/rating

Compare Oleptro with other medications

• Depression

diethylpropion

dye-eth-il-PROE-pee-on hye-droe-KLOR-ide

Commonly used brand name(s)

In the U.S.

• Tenuate


• Tenuate Dospan

Available Dosage Forms:

• Tablet, Extended Release


• Tablet

Therapeutic Class: Appetite Suppressant, Centrally Acting

Chemical Class: Diethylpropion

Uses For diethylpropion

Diethylpropion is used as part of a short-term plan, along with a low calorie diet, for weight reduction. It is used in obese patients who have not been able to lose weight with diet and exercise alone. Diethylpropion belongs to the group of medicines known as appetite suppressants.

diethylpropion is available only with your doctor's prescription.

Before Using diethylpropion

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For diethylpropion, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to diethylpropion or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of diethylpropion in children younger than 17 years of age. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of diethylpropion in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving diethylpropion.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	B	Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking diethylpropion, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using diethylpropion with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Brofaromine


• Clorgyline


• Furazolidone


• Iproniazid


• Isocarboxazid


• Lazabemide


• Linezolid


• Moclobemide


• Nialamide


• Pargyline


• Phenelzine


• Procarbazine


• Rasagiline


• Selegiline


• Sibutramine


• Thioridazine


• Toloxatone


• Tranylcypromine

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of diethylpropion. Make sure you tell your doctor if you have any other medical problems, especially:

• Agitated state or


• Arteriosclerosis (hardening of the arteries), advanced or


• Drug abuse or dependence, history of or


• Glaucoma or


• Heart problems (e.g., heart murmur, valvular heart disease) or


• Hypertension (high blood pressure), severe or


• Hyperthyroidism (overactive thyroid) or


• Pulmonary hypertension (increased blood pressure in the lungs)—Should not be used in patients with these conditions.

• Heart or blood vessel disease or


• Heart rhythm problems (e.g., arrhythmia) or


• Hypertension (high blood pressure), mild to moderate or


• Mental illness or


• Seizures or epilepsy—Use with caution. May make these conditions worse.

• Kidney disease—Use with caution. Higher blood levels of diethylpropion can occur, which increases the risk of serious side effects.

Proper Use of diethylpropion

Take diethylpropion only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. If too much is taken, it may become habit-forming (causing mental or physical dependence).

diethylpropion is available in two forms: the immediate-release tablets and the controlled-release tablets. Ask your doctor which dosage form is right for you.

Swallow the controlled-release tablets whole. Do not break, crush, or chew it.

Carefully follow your doctor's instructions for a reduced-calorie diet plan and regular exercise. Talk with your doctor before starting any exercise program.

Dosing

The dose of diethylpropion will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of diethylpropion. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For treatment of obesity:
  
  • For oral dosage form (immediate-release tablets):
    
    • Adults and teenagers 17 years of age and older—25 milligrams (mg) three times a day, taken one hour before meals, and in mid evening to overcome night hunger.
    
    
    • Children 16 years of age and younger—Use is not recommended.
    
    
  
  
  • For oral dosage form (controlled-release tablets):
    
    • Adults and teenagers 17 years of age and older—75 milligrams (mg) once a day, taken usually in mid morning.
    
    
    • Children 16 years of age and younger—Use is not recommended.
    
    
  
  

Missed Dose

If you miss a dose of diethylpropion, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Precautions While Using diethylpropion

It is very important that your doctor check your progress at regular visits to make sure that diethylpropion is working properly and does not cause any unwanted effects.

Do not use diethylpropion if you are also using similar medicines such as benzphetamine, mazindol, phendimetrazine, phentermine, Bontril®, Didrex®, or Suprenza™. Also, do not use diethylpropion if you have used an MAO inhibitor (MAOI) such as Eldepryl®, Marplan®, Nardil®, or Parnate® within the past 14 days. Using these medicines together may cause serious unwanted effects.

diethylpropion may be habit-forming. If you think diethylpropion is not working properly after you have taken it for 4 weeks, do not increase the dose. Instead, check with your doctor.

Stop using diethylpropion and check with your doctor right away if you notice a decrease in your ability to exercise, if you faint, or if you have chest pain, swelling of your feet or lower legs, or trouble with breathing. These may be symptoms of a very serious heart or lung problem.

diethylpropion may cause some people to become dizzy, lightheaded, or less alert than they are normally. Make sure you know how you react to diethylpropion before you drive, use machines, or do anything else that could be dangerous if you are dizzy or not alert.

diethylpropion will add to the effects of alcohol and other CNS depressants (medicines that make you drowsy or less alert). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; medicine for seizures (such as barbiturates); muscle relaxants; or anesthetics, including some dental anesthetics. Check with your medical doctor or dentist before taking any of the above while you are taking diethylpropion.

For diabetic patients: diethylpropion may affect blood sugar levels. If you notice a change in the results of your blood or urine sugar tests or if you have any questions, check with your doctor.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription and nonprescription (over-the-counter) medicines, dietary supplements, herbal remedies, or medicines for appetite control, asthma, colds, cough, hay fever, and sinus problems.

diethylpropion Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Rare

• Seeing, hearing, or feeling things that are not there


• severe mental changes


• shortness of breath

Incidence not known

• Black, tarry stools


• blurred vision


• burning while urinating


• chest pain


• chills


• convulsions


• cough or hoarseness


• decreased ability to exercise


• depression


• difficult or labored breathing


• difficult or painful urination


• dizziness


• fainting


• false or unusual sense of well-being


• fast, slow, pounding, or irregular heartbeat or pulse


• fear or nervousness


• fever with or without chills


• frequent urination


• general feeling of tiredness or weakness


• headache


• inability to speak


• increased volume of pale, dilute urine


• lower back or side pain


• nosebleeds


• numbness or tingling in the face, arms, or legs


• restlessness


• severe or sudden headache


• shakiness in the legs, arms, hands, or feet


• slurred speech


• sore throat


• sores, ulcers, or white spots on the lips or in the mouth


• swelling of the feet or lower legs


• swollen glands


• temporary blindness


• tightness in the chest


• trembling or shaking of the hands or feet


• trouble with breathing


• twitching, twisting, or uncontrolled repetitive movements of the tongue, lips, face, arms, or legs


• unusual bleeding or bruising


• unusual tiredness or weakness


• vision problems


• weakness in the arm or leg on one side of the body, sudden and severe


• wheezing

Get emergency help immediately if any of the following symptoms of overdose occur:

Symptoms of overdose

• Abdominal or stomach cramps


• bigger, dilated, or enlarged pupils (black part of the eye)


• change in consciousness


• confusion


• diarrhea


• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position


• increased sensitivity of the eyes to light


• loss of consciousness


• nausea


• overactive reflexes


• panic


• physical attempt to injure


• restlessness


• sweating


• violent actions


• vomiting

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

• Abdominal or stomach discomfort


• bruising


• difficulty having a bowel movement (stool)


• drowsiness


• dry mouth


• general feeling of discomfort or illness


• hair loss


• headache


• hives or welts


• indigestion


• itching


• large, flat, blue, or purplish patches in the skin


• loss of appetite


• muscle pain


• passing of gas


• redness of the skin


• skin rash


• sleeplessness


• stomach fullness or discomfort


• trouble sleeping


• unable to sleep


• unpleasant taste

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

Ran-Ramipril

Ran-Ramipril may be available in the countries listed below.

Ingredient matches for Ran-Ramipril

Ramipril

Ramipril is reported as an ingredient of Ran-Ramipril in the following countries:

• South Africa

International Drug Name Search

Stenorol

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Stenorol

Bacitracin

Bacitracin methylene disalicylate (a derivative of Bacitracin) is reported as an ingredient of Stenorol in the following countries:

• United States

Bambermycin

Bambermycin is reported as an ingredient of Stenorol in the following countries:

• United States

Halofuginone

Halofuginone hydrobromide (a derivative of Halofuginone) is reported as an ingredient of Stenorol in the following countries:

• United States

Lincomycin

Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Stenorol in the following countries:

• United States

Roxarsone

Roxarsone is reported as an ingredient of Stenorol in the following countries:

• United States

Virginiamycin

Virginiamycin is reported as an ingredient of Stenorol in the following countries:

• United States

International Drug Name Search

Biurto Forte

Biurto Forte may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Biurto Forte

Thiamine

Thiamine hydrochloride (a derivative of Thiamine) is reported as an ingredient of Biurto Forte in the following countries:

• Italy

International Drug Name Search

Perlic

Perlic may be available in the countries listed below.

Ingredient matches for Perlic

Frovatriptan

Frovatriptan succinate monohydrate (a derivative of Frovatriptan) is reported as an ingredient of Perlic in the following countries:

• Spain

International Drug Name Search

Lacri-Vision

Lacri-Vision may be available in the countries listed below.

Ingredient matches for Lacri-Vision

Hypromellose

Hypromellose is reported as an ingredient of Lacri-Vision in the following countries:

• Germany

International Drug Name Search

Metronidazol Bottle-Pack

Metronidazol Bottle-Pack may be available in the countries listed below.

Ingredient matches for Metronidazol Bottle-Pack

Metronidazole

Metronidazole is reported as an ingredient of Metronidazol Bottle-Pack in the following countries:

• Colombia

International Drug Name Search